Latest Mergers And Acquisitions News

Page 303 of 1355
Bega Cheese Limited reported a strong half-year performance with a 5% revenue increase and a 55% jump in net profit, alongside a higher interim dividend and ongoing operational consolidation.
Victor Sage
Victor Sage
19 Feb 2026
Medibank Private Limited reported a 6% rise in operating profit for the half-year ended December 2025, despite an 11% drop in net profit after tax amid ongoing cybercrime-related costs and legal challenges. The company also raised its interim dividend by 6.4%, signalling confidence in its capital position and growth strategy.
Ada Torres
Ada Torres
19 Feb 2026
SkyCity Entertainment Group posted a solid half-year profit increase to NZD 12.1 million despite a slight revenue dip, bolstered by a major equity raise and a clean bill on its Adelaide casino licence.
Victor Sage
Victor Sage
19 Feb 2026
Infragreen Group Limited reports a remarkable turnaround with a statutory net profit of A$3.64 million for H1 2025 and declares its inaugural interim dividend, underscoring confidence in its sustainable infrastructure investments.
Nora Hopper
Nora Hopper
18 Feb 2026
Glennon Small Companies Limited reported a half-year loss for the period ending 31 December 2025, driven by significant investment portfolio losses. Despite this, the company declared dividends and extended a key convertible loan.
Claire Turing
Claire Turing
18 Feb 2026
Austco Healthcare has reported a robust first half of 2026, with revenue surging 31% and EBITDA jumping 60%, underpinned by solid contract backlog and debt-free balance sheet.
Ada Torres
Ada Torres
18 Feb 2026
AuMEGA Metals has successfully upsized its institutional financing to C$30.1 million, anchored by Condire Investors who will hold nearly 20% of the company. The funds will accelerate exploration programs across its Newfoundland gold projects.
Maxwell Dee
Maxwell Dee
18 Feb 2026
Rhythm Biosciences reported a $2.26 million half-year loss as it advances ColoSTAT into commercialisation and expands geneType partnerships, signalling a pivotal phase for the ASX-listed medical diagnostics company.
Ada Torres
Ada Torres
18 Feb 2026
Nyrada Inc. reported a $3.19 million loss for the half-year ending December 2025, while advancing its lead drug candidate Xolatryp® into Phase IIa clinical trials targeting heart attack treatment.
Ada Torres
Ada Torres
18 Feb 2026
Knosys Limited reported a 4.6% revenue increase to $5.07 million for the half-year ending December 2025, driven by stronger licence and project fees. However, the company’s net loss widened significantly to $1.53 million, reflecting heavy investment in its next-generation Libero X library management system.
Sophie Babbage
Sophie Babbage
18 Feb 2026
PathKey.AI Ltd has responded to ASX inquiries about a recent spike in its share price and trading volume, confirming no undisclosed information is driving the market activity. The company points to its recent strategic update and funding completion as context for investor interest.
Sophie Babbage
Sophie Babbage
18 Feb 2026
Caterpillar has finalized its acquisition of RPMGlobal, paying shareholders A$5.00 per share and prompting RPMGlobal’s removal from the ASX. This marks a significant shift in the mining software landscape.
Sophie Babbage
Sophie Babbage
18 Feb 2026